Getinge B, SE0000202624

Getinge B stock holds steady as short interest and recent results frame the outlook

Published on 09/18/2026 at 23:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Getinge B stock recently traded around SEK 238.70 on Nasdaq Stockholm as of September 18, 2026, with modest year-to-date gains. The healthcare equipment group’s latest quarterly figures and reported short-selling positions give investors a mixed but data-rich picture.

Aquarell der Göteborger Uferpromenade mit Hochhäusern und Hafenkränen — Getinge AB (ISIN SE0000202624) präsentiert die Hafenstadt Göteborg als sanftes Aquarellgemälde mit Bürogebäuden und Kränen, Illustration mit AI erstellt.

Getinge AB B stock (ISIN SE0000202624) recently changed hands around SEK 238.70 on Nasdaq Stockholm as of September 18, 2026, with the shares showing single-digit gains since the start of the year according to an overview on Zonebourse on September 18, 2026.

Short interest and recent trading levels

According to Zonebourse on September 18, 2026, Getinge B last closed at SEK 238.70, with the stock up 1.79% over the past five trading days and 9.05% since January 1, 2026.

The same short-selling disclosure overview notes that Millennium International Management has reappeared among declared short sellers in Getinge, highlighting that hedge fund activity continues to play a role in the stock’s order book, even as the share price has drifted higher year to date.

Operational performance and margins remain in focus

Getinge’s most recent interim report for the second quarter of 2026, published on its investor-relations pages, indicated that Q2 2026 revenue rose compared with the prior-year period, while the group continued to concentrate on margin improvement in its main hospital and life-science segments, per company disclosures available through the investor-relations start page of Getinge.

In that Q2 2026 report, Getinge stated that adjusted earnings and operating margin for the quarter improved versus the same quarter of 2025, supported by product mix, pricing measures and ongoing efficiency programs, while organic order intake in key markets remained solid, according to Getinge.

Stock valuation and investor takeaway

With Getinge B stock trading around SEK 238.70 as of September 18, 2026 on Nasdaq Stockholm, and up 9.05% since January 1, 2026 as reported by Zonebourse, the stock’s recent performance reflects a balance between improving fundamentals and the presence of short sellers.